TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Sirnaomics Ltd. ( (HK:2257) ) is now available.
Sirnaomics Ltd. has announced significant changes in its board of directors, including the resignation of Ms. Monin Ung as an independent non-executive director and the appointment of Dr. Yin Huijun as a non-executive director. These changes reflect a strategic shift in the company’s leadership, potentially impacting its governance and operational focus. Dr. Yin’s extensive experience in the biotechnology sector is expected to contribute to the company’s growth and strengthen its position in the industry.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. operates in the biotechnology industry, focusing on the development of RNAi therapeutics. The company is involved in creating innovative treatments for various medical conditions, leveraging its expertise in RNA interference technology.
Average Trading Volume: 802,754
Technical Sentiment Signal: Buy
Current Market Cap: HK$971.7M
For a thorough assessment of 2257 stock, go to TipRanks’ Stock Analysis page.